All 5 uterine PDX models exhibited a TP53-mutated and MMR-proficient (MMRp) molecular landscape with a high degree of CNA and would be classified under the p53 abnormal (copy number high) molecular subgroup based on TCGA endometrial cancer molecular classification. This evidence concerns the gene TP53 and endometrial cancer.